Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
United States
Countries of investment
  • USA
Investment stages
  • Seed
Industries
  • Fintech
  • AI
  • Health Tech
  • Blockchain
  • Cryptocurrency
About
Catalio Capital Management focuses on investing in innovative biomedical technology firms established by prominent scientist entrepreneurs, leveraging their expertise to drive advancements in the field.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

Catalio’s investment thesis revolves around backing companies that are developing cuttingedge drugs, devices, diagnostics, and datadriven healthcare solutions. Their Nexus private equity strategy focuses on early to latestage biomedical companies, with a commitment to working closely with founders, building strong management teams, and partnering with toptier coinvestors.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With extensive experience in private equity, the fund manager has successfully executed over 50 deals across technology, healthcare, and consumer sectors. Active primarily in North America and Europe, their strategic style emphasizes a data-driven approach, targeting growth-stage investments. Notable exits include several high-profile sales that have significantly outperformed market averages. Their operator-first philosophy ensures hands-on involvement in portfolio companies, driving transformative growth and value creation.

Catalio Capital Contacts Information

Primary contact

Secondary contact

Team

Tom Brooks

Olly Butcher

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp